|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Nitroprusside#Drug Interactions]] |
| {{Nitroprusside}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Drug Interactions==
| |
| | |
| The hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs, including ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NITROPRESS (SODIUM NITROPRUSSIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a44bcac-a0e1-4069-5691-db7b83dbb4b7 | publisher = | date = | accessdate = 27 February 2014 }}</ref>
| |
| | |
| ==References ==
| |
| {{Reflist|2}}
| |
| | |
| {{Nonsympatholytic vasodilatory antihypertensives}}
| |
| | |
| [[Category:Cyanides]]
| |
| [[Category:Vasodilators]]
| |
| [[Category:Coordination compounds]]
| |
| [[Category:World Health Organization essential medicines]]
| |
| [[Category:Iron compounds]]
| |
| [[Category:Nitrosyl compounds]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |